
Corona Remedies IPO Subscription Status – IPO Closed
Corona Remedies IPO subscription status started on Monday December 8, 2025 and will close on December 10, 2025. Corona Remedies IPO to raise around ā¹655.37 crores via

Corona Remedies IPO subscription status started on Monday December 8, 2025 and will close on December 10, 2025. Corona Remedies IPO to raise around ā¹655.37 crores via

Good News for eagerly waiting investors! We are about to enter December 2025, and there are various current ipo this month.
This will allow you to invest in IPOs

Hindustan Construction Company Rights issue date is fixed, the rights issue is to open on December 12, 2025 and will close on December 22, 2025. The Hindustan Construction Company Rights

Patel Engineering Rights issue date is fixed, the rights issue is to open on December 12, 2025 and will close on December 19, 2025. The Patel Engineering Rights issue record

Jainex Aamcol Rights issue date is fixed, the rights issue is to open on December 1, 2025 and will close on December 9, 2025. The Jainex Aamcol Rights issue record

Ace Software Exports Rights issue date is fixed, the rights issue is to open on November 28, 2025 and will close on December 15, 2025. The Ace Software Exports Rights

Indowind Energy Rights issue date is fixed, the rights issue is to open on December 1, 2025 and will close on December 9, 2025. The Indowind Energy Rights issue record

Prachay Capital Secured, Redeemable, Non-Convertible Debentures (Secured NCDs) subscription to start on December 11, 2025. Prachay Capital will offer 13.80% interest rates on the NCDs. Prachay Capital NCD has a

The Luxury Time IPO allotment status is now available on the allotment date on December 9, 2025, Tuesday. The Luxury Time IPO subscription was ended on December 8, 2025, Monday.

The Western Overseas IPO allotment status is now available on the allotment date on December 9, 2025, Tuesday. The Western Overseas IPO subscription was ended on December 8, 2025, Monday.

Shri Kanha Stainless IPO is listed with a discount of 2.22% at ā¹88 on the NSE (National Stock Exchange). The IPO GMP of this IPO was ā¹0 last heard.

Aequs IPO listing gain is 12.90% on BSE and NSE; the stock opened at ā¹140.
The IPO GMP was ā¹28 last heard.